CELEX: 62017TN0182
Language: en
Date: 2017-03-20 00:00:00
Title: Case T-182/17: Action brought on 20 March 2017 — Novartis v EUIPO — Chiesi Farmaceutici (AKANTO)

22.5.2017   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 161/32
            
         Action brought on 20 March 2017 — Novartis v EUIPO — Chiesi Farmaceutici (AKANTO)
   (Case T-182/17)
   (2017/C 161/46)
   Language in which the application was lodged: English
   
      Parties
   
   
      Applicant: Novartis AG (Basel, Suisse) (represented by: L. Junquera Lara, lawyer)
   
      Defendant: European Union Intellectual Property Office (EUIPO)
   
      Other party to the proceedings before the Board of Appeal: Chiesi Farmaceutici SpA (Parma, Italy)
   
      Details of the proceedings before EUIPO
   
   
      Applicant of the trade mark at issue: Applicant
   
      Trade mark at issue: EU word mark ‘AKANTO’ — Application for registration No 13 289 781
   
      Procedure before EUIPO: Opposition proceedings
   
      Contested decision: Decision of the First Board of Appeal of EUIPO of 9 January 2017 in Case R 531/2016-1
   
      Form of order sought
   
   The applicant claims that the Court should:
   
               —
            
            
               annul the contested decision;
            
         
               —
            
            
               declare that Article 8(1)(b) of Regulation No 207/2009 does not preclude the sign at issue (European trade mark No 13 289 781) in respect of the goods in class 5 described in the application for registration;
            
         
               —
            
            
               order EUIPO to pay the costs.
            
         
      Plea in law
   
   
               —
            
            
               Infringement of Article 8(1)(b) of Regulation No 207/2009.